The additional flowering area consists of three modular 10,000 sq. ft. flowering rooms representing the most recent innovation of 7ACRES' hybrid cultivation methodology, its parent company Supreme Pharmaceuticals said in a media release.

"Our mission at Supreme is to drive innovation in commercial production of legal, premium cannabis," said John Fowler CEO of Supreme. "Since inception we have focused on refining and improving our cultivation infrastructure, management systems and standard operating procedures.”

Fowler said the operational experience 7ACRES accumulated in 2016 was used to design and develop the new flowering rooms, incorporating feedback from operators as well as their team of engineers and consultants.

“I am proud of the progress we have made as an organization, and I'm excited to see the new levels of quality we can achieve moving forward," said Fowler.